Catheter Precision Inc
VTAKBuild a strategy around VTAK
Catheter Precision Inc AI Insights
Informational only. Not investment advice.Snapshot
- Tangible book value is -16.0M with goodwill of 22.7M representing 335% of equity - severe impairment risk if acquired assets underperform.[Tangible Book Value]
- Cash of 1.1M vs quarterly burn of 2.4M implies <6 months runway without dilutive financing or debt.[Cash and Equivalents]
- Revenue TTM of 730K grew 135% YoY but generates -17.5M net loss - scale far from breakeven.[Total Revenue TTM]
Watch Triggers
- Cash and Equivalents: Falls below 500K or financing announced — Sub-500K cash triggers going concern; financing terms reveal dilution magnitude.
- Total Revenue TTM: Quarterly revenue exceeds 300K consistently — At 1.2M annual run-rate with 92% gross margin, path to cash breakeven emerges.
- Goodwill and Other Intangible Assets: Impairment charge recorded — 22.7M goodwill impairment would result in negative equity and potential covenant breach.
Bull Case
92.6% gross margin TTM (vs 53% industry median) proves unit economics work if scale achieved - path to profitability exists.
Revenue 3Y CAGR of 237% demonstrates product-market fit in medical devices; 135% YoY growth accelerating.
Bear Case
Imminent liquidity crisis: 1.1M cash, -2.9M working capital, 2.0M current debt - dilution or bankruptcy risk is high.
Goodwill of 22.7M on 6.8M equity creates -16.0M tangible book - any write-down wipes out equity entirely.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage VTAK's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Capital raise or strategic transaction likely within 6 months given cash constraints.
- Cash of 1.1M vs 9.6M annual burn
- Working capital deficit of -2.9M
- Current debt of 2.0M due near-term
Valuation Context
Caveats
Public Strategies Rankings
See how Catheter Precision Inc ranks across different investment strategies.
Leverage VTAK's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
VTAK Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$1.53M | — | ||
$5.28M | — | ||
0.00 | — | ||
$819,000 | +95.0% | — | |
$-15.90 | — | ||
-1,487% | +1189.6% | — | |
-2,098% | +1864.6% | — | |
$-8.43M | — | ||
-183% | -81.7% | — | |
Beta 5Y (Monthly) | unknown | — |
VTAK Dividend History
VTAK Stock Splits
VTAK SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
03/31/26 | 12/31/25 | 10-K | |
11/13/25 | 09/30/25 | 10-Q | |
08/11/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
03/31/25 | 12/31/24 | Unknown | |
11/14/24 | 09/30/24 | 10-Q | |
08/14/24 | 06/30/24 | 10-Q | |
05/06/24 | 03/31/24 | 10-Q | |
04/01/24 | 12/31/23 | 10-K | |
12/21/23 | 09/30/23 | 10-Q | |
12/15/23 | 06/30/23 | 10-Q | |
06/02/23 | 03/31/23 | 10-Q | |
03/28/23 | 12/31/22 | 10-K | |
11/14/22 | 09/30/22 | 10-Q | |
08/16/22 | 06/30/22 | 10-Q | |
05/16/22 | 03/31/22 | 10-Q | |
03/24/22 | 12/31/21 | 10-K | |
11/15/21 | 09/30/21 | 10-Q | |
08/11/21 | 06/30/21 | 10-Q | |
05/12/21 | 03/31/21 | 10-Q | |
03/17/21 | 12/31/20 | 10-K | |
11/16/20 | 09/30/20 | 10-Q | |
08/11/20 | 06/30/20 | 10-Q | |
05/14/20 | 03/31/20 | 10-Q | |
03/11/20 | 12/31/19 | 10-K | |
11/29/19 | 09/30/19 | 10-Q | |
11/29/19 | 06/30/19 | 10-Q | |
05/14/19 | 03/31/19 | 10-Q | |
03/15/19 | 12/31/18 | 10-K | |
11/14/18 | 09/30/18 | 10-Q | |
09/27/18 | 06/30/18 | 424B4 | |
07/16/18 | 03/31/18 | S-1 | |
09/27/18 | 12/31/17 | 424B4 | |
11/14/18 | 09/30/17 | 10-Q | |
06/30/17 | 06/30/17 | Unknown | -- |
07/16/18 | 03/31/17 | S-1 |